G
Gernot Marx
Researcher at RWTH Aachen University
Publications - 323
Citations - 8497
Gernot Marx is an academic researcher from RWTH Aachen University. The author has contributed to research in topics: Intensive care & Medicine. The author has an hindex of 39, co-authored 280 publications receiving 6266 citations. Previous affiliations of Gernot Marx include University of Liverpool & University of Jena.
Papers
More filters
Journal ArticleDOI
Performance of cardiac output measurement derived from arterial pressure waveform analysis in patients undergoing high-dose vasopressor-therapy: 3AP9–7
Journal ArticleDOI
The Potential Impact of Heparanase Activity and Endothelial Damage in COVID-19 Disease
Elisabeth Zechendorf,Katharina Dorothea Ilse Lidy Schröder,Lara Stiehler,Nadine Frank,Christian Beckers,Sandra Kraemer,Michael Dreher,A Kersten,Christoph Thiemermann,Gernot Marx,Tim-Philipp Simon,Lukas Martin +11 more
TL;DR: Heparanase activity and heparan sulfate levels correlate with COVID-19 disease severity and outcome, and both biomarkers might be helpful in predicting clinical course and outcomes in CO VID-19 patients.
Journal ArticleDOI
Increase of urinary TIMP-2 and IGFBP7 as potential predictor of acute kidney injury requiring renal replacement therapy and patients' outcome following complex endovascular and open thoracic abdominal aortic aneurysm surgery - a prospective observational study.
Alexander Gombert,Drosos Kotelis,Marcia Viviane Rückbeil,Mohammad E. Barbati,Lukas Martin,Gernot Marx,Jochen Grommes,Michael J. Jacobs,Gereon Schälte +8 more
TL;DR: TIMP2 × IGFBP7 level measured 6-12 hrs postoperatively may be useful as an early detectable biomarker for AKI requiring temporary renal replacement therapy but seems not suited to predict patients' outcome following complex thoracoabdominal aortic surgery.
Journal ArticleDOI
[Erratum to: Standardized contrast-enhanced ultrasound (CEUS) in clinical acute and emergency medicine and critical care (CEUS Acute) : Consensus statement of DGIIN, DIVI, DGINA, DGAI, DGK, ÖGUM, SGUM and DEGUM].
Journal ArticleDOI
Intensive care medicine: new insights to improve care.
TL;DR: Intensive care intensivists are dealing rather with syndromes than with clearly defined diseases and additionally dealing with a patient population that is very heterogeneous, so it is not easy to create robust scientific evidence.